Hu Li

28PUBLICATIONS
161CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 20, 2026
BCLXL blockade rewires cell fate to overcome PARP inhibitor resistance in ovarian cancer.

|Feb 25, 2026
Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics.

Ming-Fen Ho, Cheng Zhang, Brandon J Coombes

|Jun 04, 2025
Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.

Xiujuan Zhu, August J John, Li Wang

|Feb 14, 2025
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Nov 20, 2024
Nuclear receptor-SINE B1 network modulates expanded pluripotency in blastoids and blastocysts.

Ka Wai Wong, Yingying Zeng, Edison Tay

|Mar 27, 2024
Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study.

Ming-Fen Ho, Cheng Zhang, Irene Moon

Pageof 5

Frequent Collaborators

5 joint publications

Victor M Karpyak

5 joint publications

Richard Weinshilboum

5 joint publications

Joanna M Biernacka

4 joint publications

Darren J Baker